Business profile

Vasara Pharma Analytics Oy

Vasara Pharma Analytics Oy's registered office is Helsingfors. It is a limited company. The company was established on 2023-10-02. It operates in the industry of other information technology and computer service activities. In its latest retained statement for 2025-12-31, revenue was €142,294 and operating profit was €56,039.

Business ID 3390296-7ValidUnclaimed company profile

Trusted core data

Public company details from the trade register.

Business ID
3390296-7
Sector
Other information technology and computer service activities
Municipality
Helsingfors
Company form
Limited company
Registration date
2023-10-02
Business ID registration date
2023-09-15
Business status
Valid
Profile ownership
Unclaimed company profile

Contact and location summary

Visiting address: Aidasmäentie 23 A 2, 00650, Helsingfors

People and decision-makers

Helkimo Niko PetteriToimitusjohtaja

About Vasara Pharma Analytics Oy

Financial position and key figures for the company.

Vasara Pharma Analytics Oy's location municipality is Helsingfors. It is a limited company. The company was established on 2023-10-02. It operates in the industry of other information technology and computer service activities. In its latest retained statement for 2025-12-31, revenue was €142,294 and operating profit was €56,039. The latest retained financial statement for 2025-12-31 shows revenue of €142,294 and profit for the financial year of €46,844. Based on the latest retained statement, revenue growth was +101.7%, operating margin was +39.4%, and equity ratio was +71.7%.

Extended business activity

A longer directory- or registry-backed activity description that complements the short registry industry label.

tietotekninen palvelutoiminta ja muu laillinen liiketoiminta

Financial highlights

Key figures from the latest financial period.

Latest financial period

2025-12-31

Imported periods0
PRH parsed0
Profile sourceEnriched source observation
Derived indicators
Revenue growth101.7%
Operating margin39.4%
Equity ratio71.7%
Balance-sheet contextLatest financial period
Profit before taxes€56,041Previous: €10,528
Employees2Previous: 2
Revenue trend2 periods
€70,550
2024-12-31
€142,294
2025-12-31
Operating profit (loss) trend2 periods
€10,524
2024-12-31
€56,039
2025-12-31
Profit (loss) for the financial year trend2 periods
€8,422
2024-12-31
€46,844
2025-12-31
Assets trend2 periods
€35,100
2024-12-31
€83,163
2025-12-31

Financial ratios

Financial ratios based on financial statement data. Source: Rikastettu lähdehavainto.

Equity ratioGood
90/100 · Improving
71.7 %2024-12-31: 38.2 %
Current ratioNot assessable
0/100 · Trend unavailable
Not available2024-12-31: Ei saatavilla
Operating profit marginGood
100/100 · Improving
39.4 %2024-12-31: 14.9 %
Ratio history
Ratio2024-12-312025-12-31
Equity ratio38.2 %71.7 %
Current ratio--
Operating profit margin14.9 %39.4 %

Registry status and identifiers

Current registry information and identifiers based on YTJ data.

YTJ statusValid
Trade RegisterRegistered
Business ID3390296-7
VAT IDFI33902967
EU IDFIFPRO.3390296-7
MunicipalityHelsingfors
Current registered entries
2023-10-02Registered in Tax Administration (Tax Administration)
2023-10-02Registered in Patent and Registration Office (Trade Register)
2023-11-02VAT-liable for business activity in Tax Administration (VAT Register)
2023-11-02Registered in Tax Administration (Prepayment Register)

Responsible people

Public role relationships materialized from source observations.

Helkimo Niko PetteriToimitusjohtajaSources: 6 · Confidence: 78%
Rauhamäki Joona TapioPuheenjohtajaSources: 6 · Confidence: 78%
Helkimo Niko PetteriVarsinainen jäsenSources: 3 · Confidence: 78%
Rauhamäki Milla KaroliinaVarajäsenSources: 2 · Confidence: 78%

Risk certificate

An open-data based company stability and risk signal.

BUSINESS.fi

BUSINESS.fi Luottoluokitus

Profile-specific risk signal based on open data

Automatic gradeNot a credit decision
A3
GoodVasara Pharma Analytics Oy
Model score77/100
Assessment confidenceMedium
Evidence qualityStrong financial evidenceFinancial data included
Financial trajectorySeveral key financial indicators show coordinated recovery.
2 comparable periods
RevenueImproving
ProfitabilityImproving
SolvencyImproving
LiquidityNot enough history
Supporting factors
  • Strong equity ratio
  • Strong operating profitability
  • Coordinated recovery across 3 financial domains
Risk factors to note
  • Elevated industry distress context
Automatic model gradeA3
Automatic model snapshot2026-10-14
Automatic model versionopen-risk-grade-v0.14
Financial data included

The grade can use open digital financial statement data together with registry signals.

Verify assessment

Risk context

When sufficient source-backed financial metrics are not available for a Tier 1 assessment, BUSINESS.fi shows registry, industry, and regional context.

Industry riskelevated
49/100

Industry context is elevated based on normalized open statistical inputs.

Age and continuityNuori
35/100

The company has about 3 years of registry continuity.

Registry and status signalsRajallinen
42/100

Registry history, filing recency, and active register markings are still limited or mixed.

Events & news

Verified events and sourced external company news in one timeline.

Risk grade updatedRisk gradeEvidence verified
14 Oct 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade A3.

Registry timeline

Trade register notifications shown on a timeline.

4 register eventsLatest event: 2026-02-28

Profile source and ownership

Profile based on public registry data
BUSINESS.fi has created this profile from public company information. Source data updated 2025-12-31.

This company profile has not been claimed yet

Vasara Pharma Analytics Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.